BCL2 and hepatoblastoma: In mouse hepatoma (Hepa-1) and human hepatoblastoma (HepG2) cells, NRF2 activation upregulated the antiapoptotic protein Bcl-2, prevented apoptosis, and increased tumor cell survival and growth/proliferation [71].